EP-026856

N/A

Report date: 2025/01/26 19:24:46
NME

Base Information

Drug NameEP-026856
Drug Alias NameASK-1 inhibitor (Enanta Pharmaceuticals)Apoptosis Signal Regulating Kinase 1 Inhibitor (Enanta Pharmaceuticals)EP-026856
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis signal-regulating kinase 1 inhibitors
TargetsApoptosis signal-regulating kinase 1
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnanta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A